Myosin light chain kinase inhibitor ML7 improves vascular endothelial dysfunction via tight junction regulation in a rabbit model of atherosclerosis

Cheng,Xiaowen; Wang,Xiaobian; Wan,Yufeng; Zhou,Qing; Zhu,Huaqing; Wang,Yuan

doi:10.3892/mmr.2015.3973

Myosin light chain kinase inhibitor ML7 improves vascular endothelial dysfunction via tight junction regulation in a rabbit model of atherosclerosis

Authors:
- Xiaowen Cheng
- Xiaobian Wang
- Yufeng Wan
- Qing Zhou
- Huaqing Zhu
- Yuan Wang
View Affiliations

Affiliations: Department of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230032, P.R. China, Laboratory of Molecular Biology and Department of Biochemistry, Anhui Medical University, Hefei, Anhui 230032, P.R. China, Department of Otolaryngology, The Affiliated Chaohu Hospital of Anhui Medical University, Hefei, Anhui 230032, P.R. China
Published online on: June 22, 2015 https://doi.org/10.3892/mmr.2015.3973
Pages: 4109-4116
Copyright: © Cheng et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Vascular endothelial dysfunction (VED) is an important factor in the initiation and development of atherosclerosis (AS). Previous studies have demonstrated that endothelial permeability is increased in diet‑induced AS. However, the precise underlying mechanisms remain poorly understood. The present study aimed to analyze whether the myosin light chain kinase (MLCK) inhibitor ML7 is able to improve VED and AS by regulating the expression of the tight junction (TJ) proteins zona occludens (ZO)‑1 and occludin via mechanisms involving MLCK and MLC phosphorylation in high‑fat diet‑fed rabbits. New Zealand white rabbits were randomly divided into three groups: Control group, AS group and ML7 group. The rabbits were fed a standard diet (control group), a high‑fat diet (AS group) or a high‑fat diet supplemented with 1 mg/kg/day ML7 (ML7 group). After 12 weeks, endothelium‑dependent relaxation and endothelium‑independent relaxation were measured using high-frequency ultrasound. Administration of a high‑fat diet significantly increased the levels of serum lipids and inflammatory markers in the rabbits in the AS group, as compared with those in the rabbits in the control group. Furthermore, a high‑fat diet contributed to the formation of a typical atherosclerotic plaque, as well as an increase in endothelial permeability and VED. These symptoms of AS were significantly improved following treatment with ML7, as demonstrated in the ML7 group. Hematoxylin & eosin and immunohistochemical staining indicated that ML7 was able to decrease the expression of MLCK and MLC phosphorylation in the arterial wall of rabbits fed a high‑fat diet. A similar change was observed for the TJ proteins ZO‑1 and occludin. In addition, western blot analysis demonstrated that ML7 increased the expression levels of occludin in the precipitate, but reduced its expression in the supernatant of lysed aortas. These results indicated that occludin, which is a dynamic protein at the TJ, is associated with remodeling from cell membrane to cytoplasm. The present study was the first, to the best of our knowledge, to indicate that ML7 may ameliorate VED and AS by regulating the TJ proteins ZO‑1 and occludin via mechanisms involving MLCK and MLC phosphorylation.

View Figures

View References

1	McDermott DH, Halcox JP, Schenke WH, et al: Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res. 89:401–407. 2001. View Article : Google Scholar : PubMed/NCBI
2	Frohlich J and Al-Sarraf A: Cardiovascular risk and atherosclerosis prevention. Cardiovasc Pathol. 22:16–18. 2013. View Article : Google Scholar
3	Libby P, Ridker PM and Hansson GK: Progress and challenges in translating the biology of atherosclerosis. Nature. 473:317–325. 2011. View Article : Google Scholar : PubMed/NCBI
4	Kalwa H, Sartoretto JL, Martinelli R, et al: Central role for hydrogen peroxide in P2Y1 ADP receptor-mediated cellular responses in vascular endothelium. Proc Natl Acad Sci USA. 111:3383–3388. 2014. View Article : Google Scholar : PubMed/NCBI
5	Horio E, Kadomatsu T, Miyata K, et al: Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression. Arterioscler Thromb Vasc Biol. 34:790–800. 2014. View Article : Google Scholar : PubMed/NCBI
6	Alvarez-García V, González A, Alonso-González C, et al: Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells. J Pineal Res. 54:373–380. 2013.
7	d'Uscio LV, He T, Santhanam AV, et al: Mechanisms of vascular dysfunction in mice with endothelium-specific deletion of PPAR-δ gene. Am J Physiol Heart Circ Physiol. 306:H1001–H1010. 2014. View Article : Google Scholar : PubMed/NCBI
8	Sandoo A, Chanchlani N, Hodson J, et al: Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: A six-year prospective study. Arthritis Res Ther. 15:R2032013. View Article : Google Scholar : PubMed/NCBI
9	Robert J, Weber B, Frese L, et al: A three-dimensional engineered artery model for in vitro atherosclerosis research. PLoS One. 8:e798212013. View Article : Google Scholar : PubMed/NCBI
10	Chattopadhyay R, Dyukova E, Singh NK, et al: Vascular endothelial tight junctions and barrier function are disrupted by 15(S)-hydroxyeicosatetraenoic acid partly via protein kinase C ε-mediated zona occludens-1 phosphorylation at threonine 770/772. J Biol Chem. 289:3148–3163. 2014. View Article : Google Scholar :
11	Hu ZP, Fang XL, Fang N, et al: Melatonin ameliorates vascular endothelial dysfunction, inflammation and atherosclerosis by suppressing the TLR4/NF-κB system in high-fat-fed rabbits. J Pineal Res. 55:388–398. 2013.PubMed/NCBI
12	D'Agnillo F, Williams MC, Moayeri M and Warfel JM: Anthrax lethal toxin downregulates claudin-5 expression in human endothelial tight junctions. PLoS One. 8:e625762013. View Article : Google Scholar : PubMed/NCBI
13	Lampugnani MG: Endothelial cell-to-cell junctions: Adhesion and signaling in physiology and pathology. Cold Spring Harb Perspect Med. 2:a0065282012. View Article : Google Scholar : PubMed/NCBI
14	Collins NT, Cummins PM, Colgan OC, et al: Cyclic strain-mediated regulation of vascular endothelial occludin and ZO-1: Influence on intercellular tight junction assembly and function. Arterioscler Thromb Vasc Biol. 26:62–68. 2006. View Article : Google Scholar
15	Briasoulis A, Tousoulis D, Androulakis ES, et al: Endothelial dysfunction and atherosclerosis: Focus on novel therapeutic approaches. Recent Pat Cardiovasc Drug Discov. 7:21–32. 2012. View Article : Google Scholar : PubMed/NCBI
16	Sawada N, Jiang A, Takizawa F, et al: Endothelial PGC-1α mediates vascular dysfunction in diabetes. Cell Metab. 19:246–258. 2014. View Article : Google Scholar : PubMed/NCBI
17	Bonetti PO, Lerman LO and Lerman A: Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 23:168–175. 2003. View Article : Google Scholar : PubMed/NCBI
18	Woo A, Shin W, Cuong TD, et al: Arginase inhibition by piceatannol-3′-O-β-D-glucopyranoside improves endothelial dysfunction via activation of endothelial nitric oxide synthase in ApoE-null mice fed a high-cholesterol diet. Int J Mol Med. 31:803–810. 2013.PubMed/NCBI
19	Yuan SY: Protein kinase signaling in the modulation of micro-vascular permeability. Vascul Pharmacol. 39:213–223. 2002. View Article : Google Scholar
20	Rashid G, Bernheim J, Green J and Benchetrit S: Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Renal Physiol. 292:F1215–F1218. 2007. View Article : Google Scholar
21	Zhu HQ, Zhou Q, Jiang ZK, Gui SY and Wang Y: Association of aorta intima permeability with myosin light chain kinase expression in hypercholesterolemic rabbits. Mol Cell Biochem. 347:209–215. 2011. View Article : Google Scholar
22	Pinto JR, Gomes AV, Jones MA, et al: The functional properties of human slow skeletal troponin T isoforms in cardiac muscle regulation. J Biol Chem. 287:37362–37370. 2012. View Article : Google Scholar : PubMed/NCBI
23	Rodella LF, Favero G, Foglio E, et al: Vascular endothelial cells and dysfunctions: Role of melatonin. Front Biosci (Elite Ed). 5:119–129. 2013.
24	Eutamene H, Theodorou V, Schmidlin F, et al: LPS-induced lung inflammation is linked to increased epithelial permeability: Role of MLCK. Eur Respir J. 25:789–796. 2005. View Article : Google Scholar : PubMed/NCBI
25	Zhu HQ, Wang XB, Han JX, et al: Myoson light chain kinase inhibitor attenuates atherosclerosis and permeability via reduced endothelial tight junction in rabbits. Int J Cardiol. 168:5042–5043. 2013. View Article : Google Scholar : PubMed/NCBI
26	Chen YX, Wang XQ, Fu Y, et al: Pivotal role of inflammation in vascular endothelial dysfunction of hyperlipidemic rabbit and effects by atorvastatin. Int J Cardiol. 146:140–144. 2011. View Article : Google Scholar
27	Drolet MC, Plante E, Battistini B, et al: Early endothelial dysfunction in cholesterol-fed rabbits: A non-invasive in vivo ultrasound study. Cardiovasc Ultrasound. 2:102004. View Article : Google Scholar : PubMed/NCBI
28	Zhou B, Pan Y, Hu Z, et al: All-trans-retinoic acid ameliorated high fat diet-induced atherosclerosis in rabbits by inhibiting platelet activation and inflammation. J Biomed Biotechnol. 2012:2596932012. View Article : Google Scholar : PubMed/NCBI
29	Cheng X, Wan Y, Xu Y, Zhou Q, Wang Y and Zhu H: Melatonin alleviates myosin light chain kinase expression and activity via the mitogen-activated protein kinase pathway during atherosclerosis in rabbits. Mol Med Rep. 11:99–104. 2015.
30	Hirase T and Node K: Endothelial dysfunction as a cellular mechanism for vascular failure. Am J Physiol Heart Circ Physiol. 302:H499–H505. 2012. View Article : Google Scholar
31	Rossi JL, Ralay Ranaivo H, Patel F, et al: Albumin causes increased myosin light chain kinase expression in astrocytes via p38 mitogen-activated protein kinase. J Neurosci Res. 89:852–861. 2011. View Article : Google Scholar : PubMed/NCBI
32	Koga T, Kwan P, Zubik L, et al: Vitamin E supplementation suppresses macrophage accumulation and endothelial cell expression of adhesion molecules in the aorta of hypercholesterolemic rabbits. Atherosclerosis. 176:265–272. 2004. View Article : Google Scholar : PubMed/NCBI
33	Sun C, Wu MH and Yuan SY: Nonmuscle myosin light-chain kinase deficiency attenuates atherosclerosis in apolipoprotein E-deficient mice via reduced endothelial barrier dysfunction and monocyte migration. Circulation. 124:48–57. 2011. View Article : Google Scholar : PubMed/NCBI
34	Wang B, Yan Y, Zhou J, et al: A novel all-trans retinoid acid derivatives inhibits the migration of breast cancer cell lines MDA-MB-231 via myosin light chain kinase involving p38-MAPK pathway. Biomed Pharmacother. 67:357–362. 2013. View Article : Google Scholar : PubMed/NCBI
35	Yamazaki T, Nohara R, Daida H, et al Justification for Atherosclerosis Regression Treatment (JART) Investigators: Intensive lipid-lowering therapy for slowing progression as well as inducing regression of atherosclerosis in Japanese patients: Subanalysis of the JART study. Int Heart J. 54:33–39. 2013. View Article : Google Scholar : PubMed/NCBI
36	Goddard LM and Iruela-Arispe ML: Cellular and molecular regulation of vascular permeability. Thromb Haemost. 109:407–415. 2013. View Article : Google Scholar : PubMed/NCBI
37	Oldenburg J and de Rooij J: Mechanical control of the endothelial barrier. Cell Tissue Res. 355:545–555. 2014. View Article : Google Scholar : PubMed/NCBI